MolecularMD Enters Into a Collaboration Agreement With Illumina for Drug-Diagnostic Co-Development With Biopharma Drug Programs
27 juin 2016 12h00 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - June 27, 2016) - MolecularMD Corporation announced today that it has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN) that establishes a...
MolecularMD Has Obtained CE Marking of a Diagnostic Assay Developed for a Daiichi Sankyo, Inc. Phase II Clinical Trial
25 avr. 2016 07h35 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - April 25, 2016) - MolecularMD Corp., a molecular diagnostics company that accelerates oncology drug development by providing custom companion...
MolecularMD Receives New York State Approval for Next Generation Sequencing Test to Support Clinical Trial Enrollment
16 juil. 2015 10h17 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Jul 16, 2015) - MolecularMD Corp., a molecular diagnostics company that provides companion diagnostic solutions and supporting clinical trial...
MolecularMD Receives ISO Certification for Design, Development and Production of Molecular Diagnostic Products
26 mars 2015 00h05 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Mar 26, 2015) - MolecularMD Corp., a molecular diagnostics company that develops custom companion diagnostics and provides clinical trial testing...
MolecularMD Cambridge Laboratory Receives CAP Accreditation With Focus on NGS Panels for Clinical Trial Enrollment and NGS Liquid Biopsy Testing
17 déc. 2014 22h24 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Dec 17, 2014) - MolecularMD, Corp., a molecular diagnostics company that develops custom companion diagnostic products and supports clinical trial...
MolecularMD Develops Notch1 Next Generation Sequencing Test to Support Clinical Development for OncoMed's Anti-Notch1 Antibody, OMP-52M51
12 juin 2014 07h54 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Jun 12, 2014) - MolecularMD Corp., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial...
MolecularMD Receives CLIA Certification for Its Second Next Generation Sequencing Laboratory
04 avr. 2014 07h00 HE
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Apr 4, 2014) - MolecularMD, Inc., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial...
MolecularMD Launches NanoString Platform for Multiplexed Digital Evaluation of Gene Expression and Copy Number Variation in Clinical Specimens
05 mars 2014 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwired - Mar 5, 2014) - MolecularMD Corp. today announced that it has launched the NanoString nCounter® Analysis System for multiplex biomarker evaluation in support of...
MolecularMD to Develop Highly Sensitive Companion Diagnostic Test to Support CML Treatment Free Remission Clinical Trials
19 févr. 2014 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwired - Feb 19, 2014) - MolecularMD Corp. today announced that it has entered into a collaboration with Novartis Pharmaceuticals Corporation to develop a companion diagnostic...
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting
05 déc. 2013 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwired - Dec 5, 2013) - MolecularMD Corp., a molecular diagnostics company focused on providing the highest quality companion diagnostics and clinical trials support services to...